Mechanism of long non-coding RNA in prostate cancer

doi:10.3760/cma.j.cn371439-20200610-00023

Abstract

Abstract:

Long non-coding RNA (lncRNA) is a type of RNA molecule whose transcript is longer than 200 nucleotides and cannot encode protein. Studies in recent years have shown that lncRNA plays an important role in the physiological and pathological processes of the body. It participates in the occurrence, development and metastasis of prostate cancer. Further study on the role and mechanism of lncRNA in prostate cancer is expected to provide new ideas for the diagnosis and treatment of prostate cancer.

Key words: Prostatic neoplasms, RNA, long noncoding

Zhang Xiaofei, Hu Jianpeng, Cui Feilun. Mechanism of long non-coding RNA in prostate cancer[J]. Journal of International Oncology, 2021, 48(2): 117-120.

References 36

[1]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020,70(1):7-30. DOI: 10.3322/caac.21590. doi: 10.3322/caac.21590 pmid: 31912902
[2]	Chi Y, Wang D, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers[J]. Cells, 2019,8(9):1015. DOI: 10.3390/cells8091015. doi: 10.3390/cells8091015
[3]	Cui Z, Ren S, Lu J, et al. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor[J]. Urol Oncol, 2013,31(7):1117-1123. DOI: 10.1016/j.urolonc.2011.11.030. doi: 10.1016/j.urolonc.2011.11.030 pmid: 22264502
[4]	Yang Q, Cui ZL, Wang Q, et al. PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells[J]. Asian J Androl, 2017,19(4):453-457. DOI: 10.4103/1008-682X.178849. doi: 10.4103/1008-682X.178849 pmid: 27232851
[5]	Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis[J]. Biomed Pharmacother, 2020,123:109774. DOI: 10.1016/j.biopha.2019.109774. doi: 10.1016/j.biopha.2019.109774 pmid: 31855739
[6]	Zhu M, Chen Q, Liu X, et al. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI[J]. FEBS J, 2014,281(16):3766-3775. DOI: 10.1111/febs.12902. doi: 10.1111/febs.12902
[7]	Singh N, Padi SKR, Bearss JJ, et al. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth[J]. Mol Oncol, 2020,14(5):974-990. DOI: 10.1002/1878-0261.12662. doi: 10.1002/1878-0261.12662 pmid: 32146726
[8]	Ren S, Liu Y, Xu W, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer[J]. J Urol, 2013,190(6):2278-2287. DOI: 10.1016/j.juro.2013.07.001. doi: 10.1016/j.juro.2013.07.001 pmid: 23845456
[9]	Wang D, Ding L, Wang L, et al. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer[J]. Oncotarget, 2015,6(38):41045-41055. DOI: 10.18632/oncotarget.5728. doi: 10.18632/oncotarget.5728 pmid: 26516927
[10]	Wang F, Ren S, Chen R, et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer[J]. Oncotarget, 2014,5(22):11091-11102. DOI: 10.18632/oncotarget.2691.
[11]	Jin SJ, Jin MZ, Xia BR, et al. Long non-coding RNA DANCR as an emerging therapeutic target in human cancers[J]. Front Oncol, 2019,9:1225. DOI: 10.3389/fonc.2019.01225. doi: 10.3389/fonc.2019.01225 pmid: 31799189
[12]	Zhao HF, Zhang ZC, Shi BK, et al. DANCR sponges miR-135a to regulate paclitaxel sensitivity in prostate cancer[J]. Eur Rev Med Pharmacol Sci, 2019,23(16):6849-6857. DOI: 10.26355/eurrev_201908_18724. doi: 10.26355/eurrev_201908_18724 pmid: 31486484
[13]	Ma Y, Fan B, Ren Z, et al. Long noncoding RNA DANCR contri-butes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway[J]. Onco Targets Ther, 2019,12:5485-5497. DOI: 10.2147/OTT.S197009. doi: 10.2147/OTT.S197009 pmid: 31371987
[14]	Ji J, Dai X, Yeung SJ, et al. The role of long non-coding RNA GAS5 in cancers[J]. Cancer Manag Res, 2019,11:2729-2737. DOI: 10.2147/CMAR.S189052. doi: 10.2147/CMAR.S189052 pmid: 31114330
[15]	Xie X, Dai J, Huang X, et al. MicroRNA-145 inhibits proliferation and induces apoptosis in human prostate carcinoma by upregulating long non-coding RNA GAS5[J]. Oncol Lett, 2019,18(2):1043-1048. DOI: 10.3892/ol.2019.10419. doi: 10.3892/ol.2019.10419 pmid: 31423164
[16]	Yang J, Hao T, Sun J, et al. Long noncoding RNA GAS5 modulates α-Solanine-induced radiosensitivity by negatively regulating miR-18a in human prostate cancer cells[J]. Biomed Pharmacother, 2019,112:108656. DOI: 10.1016/j.biopha.2019.108656. doi: 10.1016/j.biopha.2019.108656 pmid: 30970507
[17]	Guo C, Qi Y, Qu J, et al. Pathophysiological functions of the lncRNA TUG1[J]. Curr Pharm Des, 2020,26(6):688-700. DOI: 10.2174/1381612826666191227154009. doi: 10.2174/1381612826666191227154009 pmid: 31880241
[18]	Xu T, Liu CL, Li T, et al. LncRNA TUG1 aggravates the progre-ssion of prostate cancer and predicts the poor prognosis[J]. Eur Rev Med Pharmacol Sci, 2019,23(11):4698-4705. DOI: 10.26355/eurrev_201906_18062. doi: 10.26355/eurrev_201906_18062 pmid: 31210308
[19]	Yang G, Yin H, Lin F, et al. Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis[J]. Pathol Res Pract, 2020,216(4):152851. DOI: 10.1016/j.prp.2020.152851. doi: 10.1016/j.prp.2020.152851 pmid: 32057513
[20]	Pu J, Wei H, Tan C, et al. Long noncoding RNA SNHG14 facilitates hepatocellular carcinoma progression through regulating miR-4673/SOCS1[J]. Am J Transl Res, 2019,11(9):5897-5904. pmid: 31632558
[21]	Li L, Zhang R, Li SJ. Long noncoding RNA SNHG14 promotes ovarian cancer cell proliferation and metastasis via sponging miR-219a-5p[J]. Eur Rev Med Pharmacol Sci, 2019,23(10):4136-4142. DOI: 10.26355/eurrev_201905_17915. doi: 10.26355/eurrev_201905_17915 pmid: 31173283
[22]	Ye T, Zhang N, Wu W, et al. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis[J]. In Vitro Cell Dev Biol Anim, 2019,55(10):812-820. DOI: 10.1007/s11626-019-00398-5. doi: 10.1007/s11626-019-00398-5 pmid: 31471872
[23]	Xu ZN, Wang ZX, Xu L, et al. Long noncoding RNA SNHG14 exerts oncogenic functions in lung adenocarcinoma through acting as a sponge to miR-613[J]. Eur Rev Med Pharmacol Sci, 2019,23(24):10810-10817. DOI: 10.26355/eurrev_201912_19784. doi: 10.26355/eurrev_201912_19784 pmid: 31858549
[24]	Liu Z, Yan Y, Cao S, et al. Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis[J]. J Cell Biochem, 2018,119(8):6905-6913. DOI: 10.1002/jcb.26889. doi: 10.1002/jcb.26889 pmid: 29667771
[25]	Ji N, Wang Y, Bao G, et al. LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ[J]. Pathol Res Pract, 2019,215(4):668-675. DOI: 10.1016/j.prp.2018.12.026. doi: 10.1016/j.prp.2018.12.026 pmid: 30611620
[26]	Sun B, Ke KB, Liu DF, et al. Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613[J]. Eur Rev Med Pharmacol Sci, 2020,24(2):633-638. DOI: 10.26355/eurrev_202001_20039. doi: 10.26355/eurrev_202001_20039 pmid: 32016964
[27]	Ghafouri-Fard S, Taheri M. Maternally expressed gene 3 (MEG3): a tumor suppressor long noncoding RNA[J]. Biomed Pharmacother, 2019,118:109129. DOI: 10.1016/j.biopha.2019.109129. doi: 10.1016/j.biopha.2019.109129 pmid: 31326791
[28]	Li J, Zi Y, Wang W, et al. Long noncoding RNA MEG3 inhibits cell proliferation and metastasis in chronic myeloid leukemia via targeting miR-184[J]. Oncol Res, 2018,26(2):297-305. DOI: 10.3727/096504017X14980882803151. doi: 10.3727/096504017X14980882803151 pmid: 28653609
[29]	Wu M, Huang Y, Chen T, et al. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis[J]. J Cell Mol Med, 2019,23(1):29-38. DOI: 10.1111/jcmm.13658. doi: 10.1111/jcmm.13658 pmid: 30565858
[30]	Luo G, Wang M, Wu X, et al. Long non-coding RNA MEG3 inhi-bits cell proliferation and induces apoptosis in prostate cancer[J]. Cell Physiol Biochem, 2015,37(6):2209-2220. DOI: 10.1159/000438577. doi: 10.1159/000438577 pmid: 26610246
[31]	Zhang WY, Liu YJ, He Y, et al. Down-regulation of long non-coding RNA ANRIL inhibits the proliferation, migration and invasion of cervical cancer cells[J]. Cancer Biomark, 2018,23(2):243-253. DOI: 10.3233/CBM-181467. doi: 10.3233/CBM-181467 pmid: 30198868
[32]	Zhang JJ, Wang DD, Du CX, et al. Long noncoding RNA ANRIL promotes cervical cancer development by acting as a sponge of miR-186[J]. Oncol Res, 2018,26(3):345-352. DOI: 10.3727/096504017X14953948675449. doi: 10.3727/096504017X14953948675449 pmid: 28550682
[33]	Yu G, Liu G, Yuan D, et al. Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorige-nesis via PI3K/Akt pathway[J]. J Bone Oncol, 2018,11:51-55. DOI: 10.1016/j.jbo.2018.02.002. doi: 10.1016/j.jbo.2018.02.002 pmid: 29520337
[34]	Deng W, Zhang Y, Cai J, et al. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-κB signaling[J]. Exp Biol Med (Maywood), 2019,244(12):953-959. DOI: 10.1177/1535370219860207. doi: 10.1177/1535370219860207
[35]	Ma J, Li T, Han X, et al. Knockdown of lncRNA ANRIL suppre-sses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2018,144(2):205-214. DOI: 10.1007/s00432-017-2543-y. doi: 10.1007/s00432-017-2543-y pmid: 29127494
[36]	Zhao B, Lu YL, Yang Y, et al. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway[J]. Cancer Biomark, 2018,21(3):613-620. DOI: 10.3233/CBM-170683. doi: 10.3233/CBM-170683 pmid: 29278879